Basic Nanomedicine: Anti-glycation activity of gold nanoparticles

Anti-glycation activity of gold nanoparticles (GNPs) has been reported for the first time. Nonenzymatic glycation of alpha -crystallin leads to formation of cataract, or opaque aggregate of proteins. In this article we report prevention of glycation of alpha -crystallin by conjugation with GNPs. For...

Full description

Saved in:
Bibliographic Details
Published in:Nanomedicine 2009-03, Vol.5 (1), p.21-29
Main Authors: Singha, Santiswarup, Bhattacharya, Jaydeep, Datta, Himadri, Dasgupta, Anjan Kumar
Format: Article
Language:English
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Anti-glycation activity of gold nanoparticles (GNPs) has been reported for the first time. Nonenzymatic glycation of alpha -crystallin leads to formation of cataract, or opaque aggregate of proteins. In this article we report prevention of glycation of alpha -crystallin by conjugation with GNPs. Formation of advanced glycosylic end products is prevented even if a strong glycating agent such as fructose is used. In addition, the nanoconjugation can provide some important information on the structural distribution of this dynamic chaperone protein. Because GNPs are biocompatible, their reported anti-glycation activity may have ophthalmological implications.
ISSN:1549-9634
DOI:10.1016/j.nano.2008.06.005